Lasmiditan Catalog No.:M10338-10 Smiles: CC1(C)[C@@H]2[C@@H](O)C[C@]3(C)[C@H](C[C@@H](O)[C@@H]4[C@H](CC[C@@]34C)[C@@](C)(O)CCC=C(C)C)[C@@]2(C)CC[C@@H]1O

Smiles: CC1(C)[C@@H]2[C@@H](O)C[C@]3(C)[C@H](C[C@@H](O)[C@@H]4[C@H](CC[C@@]34C)[C@@](C)(O)CCC=C(C)C)[C@@]2(C)CC[C@@H]1O

27-d6) is the deuterated form of Vitamin D3

3)4)35-26(38)11-9-7-5-6-8-10-12-27(39)40/h13-16

Chemical Name: (R)-3-(2

The substance is a white powder consisting of thin hexagonal plates

Lasmiditan Catalog No.:M10338-10 Smiles: CC1(C)[C@@H]2[C@@H](O)C[C@]3(C)[C@H](C[C@@H](O)[C@@H]4[C@H](CC[C@@]34C)[C@@](C)(O)CCC=C(C)C)[C@@]2(C)CC[C@@H]1OLasmiditan, also known as COL 144 and LY573144, is a novel, centrally acting, highly selective 5 HT(1F) receptor agonist (K1=2. 21 M) without vasoconstrictor activity that seemed effective when given as an intravenous infusion in a proof of concept migraine study. Lasmiditan showed efficacy in its primary endpoint, with a 2 hour placebo subtracted headache response of 28. 8%, though with frequent reports of dizziness, paresthesias, and vertigo.